Significant initial hyperglycemia in young children with intracranial hemorrhage related to abuse

Melanie M Randall1, Christine L S Lee1, Colleen Walsh Lang1

  • 1Department of Emergency Medicine, Pediatric Emergency Medicine Division, Loma Linda University Medical Center, Loma Linda, California, USA.

Brain Injury
|March 14, 2025
PubMed

Insights

Abusive head injury in young children is linked to significantly higher initial glucose levels. Extremely high glucose readings (over 300 mg/dL) in infants with head trauma strongly suggest abusive head injury.

Area of Science:

  • Pediatric Emergency Medicine
  • Neurology
  • Child Abuse Pediatrics

Background:

  • Abusive head injury (AHI) is a leading cause of mortality and morbidity in young children.
  • Hyperglycemia is frequently observed in patients with head injuries and is associated with poorer neurological outcomes.

Purpose of the Study:

  • To investigate the association between hyperglycemia and abusive head injury in pediatric patients.
  • To determine if initial glucose levels can serve as a biomarker for identifying abusive head injury.

Main Methods:

  • Retrospective review of pediatric patients under three years old presenting with traumatic intracranial hemorrhage.
  • Analysis of demographic data, laboratory values (including initial glucose), and imaging results.

Main Results:

  • 179 patients were analyzed; abusive head injury patients had a median initial glucose of 164 mg/dL compared to 99 mg/dL in non-abuse patients.
  • All eight patients with glucose levels >300 mg/dL were victims of abuse.
  • Initial glucose level was a significant predictor for child abuse diagnosis, ICU admission, neurosurgical intervention, and mortality.

Conclusions:

  • Elevated initial glucose levels, particularly >300 mg/dL, in young children with intracranial hemorrhage are highly indicative of abusive head injury.
  • A high initial glucose reading should prompt clinicians to consider abusive head injury in their differential diagnosis for critically ill infants.
Abstract

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
146
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
839
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
495
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
77